Advertisement
Advertisement
LTGO
Latigo Biotherapeutics, Inc. Common Stock
17.15
USDSponsored
-0.61
-3.43%
Sep 25, 15:59 UTC -4
Closed
After-Market
17.20
+0.05
+0.26%
Latigo Biotherapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 1.14B |
| Beta | -- |
| Earnings Per Share (EPS) | -- |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | -- |
| Free Cash Flow | 0.00 |
